A detailed history of Jefferies Group LLC transactions in Lumos Pharma, Inc. stock. As of the latest transaction made, Jefferies Group LLC holds 120,651 shares of LUMO stock, worth $518,799. This represents 0.01% of its overall portfolio holdings.

Number of Shares
120,651
Previous 120,651 -0.0%
Holding current value
$518,799
Previous $929,000 16.79%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

BUY
$7.76 - $16.99 $107,724 - $235,855
13,882 Added 13.0%
120,651 $1.99 Million
Q1 2020

May 15, 2020

BUY
$0.89 - $8.85 $95,024 - $944,905
106,769 New
106,769 $908,000

Others Institutions Holding LUMO

About LUMOS PHARMA, INC.


  • Ticker LUMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,396,070
  • Market Cap $36.1M
  • Description
  • Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...
More about LUMO
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.